ESTUTC-5 New YorkLog in Sign up

VTGN
Vistagen Therapeutics, Inc. Common Stock
stockNASDAQ

Market OpenNov 10, 2026 11:39:19 AM EST

0.18USD-2.603%(-0.00)313,509

Pre-marketNov 10, 2026 9:27:30 AM EST

0.1879USD+1.898%(+0.0035)

0.1500Bid0.2100Ask0.0600Spread

VTGN News

Day breaks

08:30 AM ESTVistagen Provides Regulatory Update Following Productive Type C Meeting with U.S. FDA on Phase 3 Development of Fasedienol for Social Anxiety Disorder ·

GlobeNewswire Inc.

05:32 PM EDTVistagen Therapeutics cuts workforce by 31% to reduce costs ·

Investing.com

08:30 AM EDTVistagen Selects GATC Health to Apply Predictive AI Across Lead Clinical-Stage Drug Development Programs ·

GlobeNewswire Inc.

07:00 AM EDTVistagen Reports Positive Findings Supporting Fasedienol’s Potential in Very Severe Social Anxiety Disorder ·

GlobeNewswire Inc.

08:30 AM EDTVistagen Announces Preliminary Positive Data from Open-Label Extension Portion of PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder ·

GlobeNewswire Inc.